Protocol for the development of an international Core Outcome Set for treatment trials in adults with epilepsy: the EPilepsy outcome Set for Effectiveness Trials Project (EPSET)

Simple item page
dc.contributor.authorMitchell, James W.
dc.contributor.authorNoble, Adam
dc.contributor.authorBaker, Gus
dc.contributor.authorBatchelor, Rachel
dc.contributor.authorBrigo, Francesco
dc.contributor.authorChristensen, Jakob
dc.contributor.authorFrench, Jacqueline
dc.contributor.authorGil-Nagel, Antonio
dc.contributor.authorGuekht, Alla
dc.contributor.authorJette, Nathalie
dc.contributor.authorKälviäinen, Reetta
dc.contributor.authorLeach, John P.
dc.contributor.authorMaguire, Melissa
dc.contributor.authorO’Brien, Terence
dc.contributor.authorRosenow, Felix
dc.contributor.authorRyvlin, Philippe
dc.contributor.authorTittensor, Phil
dc.contributor.authorTripathi, Manjari
dc.contributor.authorTrinka, Eugen
dc.contributor.authorWiebe, Samuel
dc.contributor.authorWilliamson, Paula R.
dc.contributor.authorMarson, Tony
dc.date.accessioned2022-11-20T01:02:37Z
dc.date.available2022-11-20T01:02:37Z
dc.date.issued2022-11-17
dc.date.updated2022-11-20T01:02:37Z
dc.description.abstractAbstract Background A Core Outcome Set (COS) is a standardised list of outcomes that should be reported as a minimum in all clinical trials. In epilepsy, the choice of outcomes varies widely among existing studies, particularly in clinical trials. This diminishes opportunities for informed decision-making, contributes to research waste and is a barrier to integrating findings in systematic reviews and meta-analyses. Furthermore, the outcomes currently being measured may not reflect what is important to people with epilepsy. Therefore, we aim to develop a COS specific to clinical effectiveness research for adults with epilepsy using Delphi consensus methodology. Methods The EPSET Study will comprise of three phases and follow the core methodological principles as outlined by the Core Outcome Measures in Effectiveness Trials (COMET) Initiative. Phase 1 will include two focused literature reviews to identify candidate outcomes from the qualitative literature and current outcome measurement practice in phase III and phase IV clinical trials. Phase 2 aims to achieve international consensus to define which outcomes should be measured as a minimum in future trials, using a Delphi process including an online consensus meeting involving key stakeholders. Phase 3 will involve dissemination of the ratified COS to facilitate uptake in future trials and the planning of further research to identify the most appropriate measurement instruments to use to capture the COS in research practice. Discussion Harmonising outcome measurement across future clinical trials should ensure that the outcomes measured are relevant to patients and health services, and allow for more meaningful results to be obtained. Core Outcome Set registration COMET Initiative as study 118 .
dc.identifier.citationTrials. 2022 Nov 17;23(1):943
dc.identifier.doihttps://doi.org/10.1186/s13063-022-06729-4
dc.identifier.urihttp://hdl.handle.net/1880/115513
dc.identifier.urihttps://doi.org/10.11575/PRISM/45875
dc.language.rfc3066en
dc.rights.holderThe Author(s)
dc.titleProtocol for the development of an international Core Outcome Set for treatment trials in adults with epilepsy: the EPilepsy outcome Set for Effectiveness Trials Project (EPSET)
dc.typeJournal Article
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
13063_2022_Article_6729.pdf
Size:
1.11 MB
Format:
Adobe Portable Document Format
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
0 B
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
Open Access Publications